Prospective Evaluation of a Breast Cancer Risk Model Integrating Classical Risk Factors and Polygenic Risk in 15 Cohorts from Six Countries
暂无分享,去创建一个
C. Weinberg | P. Ridker | D. Chasman | C. Vachon | K. Czene | P. Hall | C. Scott | K. Brandt | J. Chang-Claude | M. García-Closas | J. Buring | N. Chatterjee | G. Giles | M. Southey | D. Easton | P. Kraft | A. Antoniou | N. Orr | D. Evans | R. Milne | M. Schmidt | A. Swerdlow | J. Simard | N. Mavaddat | M. Brook | M. Eriksson | M. Schoemaker | W. Newman | S. Gapstur | K. Khaw | R. Kaaks | E. Harkness | C. V. van Gils | D. Sandler | S. Winham | R. MacInnis | M. Gabrielson | A. Norman | M. Gaudet | T. Ahearn | Myrto Barrdahl | B. Carter | A. Wilcox | Chi Gao | A. Hüsing | S. Sampson | M. Shi | Michael E. Jones | K. Martin | E. V. van Veen | P. Choudhury | D. Evans | P. Hall | D. Evans | D. Evans
[1] Nilanjan Chatterjee,et al. iCARE: An R package to build, validate and apply absolute risk models , 2020, PloS one.
[2] Douglas K Owens,et al. Medication Use to Reduce Risk of Breast Cancer: US Preventive Services Task Force Recommendation Statement. , 2019, JAMA.
[3] M. Somerfield,et al. Use of Endocrine Therapy for Breast Cancer Risk Reduction: ASCO Clinical Practice Guideline Update. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] X. Castells,et al. A systematic review and quality assessment of individualised breast cancer risk prediction models , 2019, British Journal of Cancer.
[5] L. Sugrue,et al. What Are Polygenic Scores and Why Are They Important? , 2019, JAMA.
[6] S. Astley,et al. Breast cancer pathology and stage are better predicted by risk stratification models that include mammographic density and common genetic variants , 2019, Breast Cancer Research and Treatment.
[7] Gord Glendon,et al. 10-year performance of four models of breast cancer risk: a validation study. , 2019, The Lancet. Oncology.
[8] S. Hankinson,et al. Breast cancer risk prediction in women aged 35–50 years: impact of including sex hormone concentrations in the Gail model , 2019, Breast Cancer Research.
[9] E. Ziv,et al. A response to “Personalised medicine and population health: breast and ovarian cancer” , 2019, Human Genetics.
[10] M. García-Closas,et al. Assessment of breast cancer risk: which tools to use? , 2019, The Lancet. Oncology.
[11] M. García-Closas,et al. Correction: BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors , 2019, Genetics in Medicine.
[12] M. García-Closas,et al. BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors , 2019, Genetics in Medicine.
[13] Kristen S Purrington,et al. Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes , 2018, American Journal of Human Genetics.
[14] V. Viallon,et al. Risk prediction for estrogen receptor-specific breast cancers in two large prospective cohorts , 2018, Breast Cancer Research.
[15] M. García-Closas,et al. Comparative validation of breast cancer risk prediction models and projections for future risk stratification , 2018, bioRxiv.
[16] M. Gail,et al. Breast Cancer Risk Model Requirements for Counseling, Prevention, and Screening , 2018, Journal of the National Cancer Institute.
[17] E. Topol,et al. The personal and clinical utility of polygenic risk scores , 2018, Nature Reviews Genetics.
[18] W. Willett,et al. Addition of a polygenic risk score, mammographic density, and endogenous hormones to existing breast cancer risk prediction models: A nested case–control study , 2018, PLoS medicine.
[19] P. Pharoah,et al. Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Screening for Breast Cancer , 2018, JAMA oncology.
[20] Jack Cuzick,et al. Long-term Accuracy of Breast Cancer Risk Assessment Combining Classic Risk Factors and Breast Density , 2018, JAMA oncology.
[21] S. Astley,et al. Use of Single-Nucleotide Polymorphisms and Mammographic Density Plus Classic Risk Factors for Breast Cancer Risk Prediction , 2018, JAMA oncology.
[22] C. Sotiriou,et al. Unravelling triple-negative breast cancer molecular heterogeneity using an integrative multiomic analysis , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.
[23] S. Cross,et al. Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study , 2017, Breast Cancer Research.
[24] J. Guan,et al. Breast Cancer: Multiple Subtypes within a Tumor? , 2017, Trends in cancer.
[25] Gary D Bader,et al. Association analysis identifies 65 new breast cancer risk loci , 2017, Nature.
[26] Jingmei Li,et al. Assessment of Breast Cancer Risk Factors Reveals Subtype Heterogeneity. , 2017, Cancer research.
[27] Danielle Braun,et al. Breast cancer risk models: a comprehensive overview of existing models, validation, and clinical applications , 2017, Breast Cancer Research and Treatment.
[28] A. Fournier,et al. Added Value of Serum Hormone Measurements in Risk Prediction Models for Breast Cancer for Women Not Using Exogenous Hormones: Results from the EPIC Cohort , 2017, Clinical Cancer Research.
[29] Mitchell H Gail,et al. Projecting Individualized Absolute Invasive Breast Cancer Risk in US Hispanic Women , 2017, Journal of the National Cancer Institute.
[30] Martin Eklund,et al. Breast Cancer Screening in the Precision Medicine Era: Risk-Based Screening in a Population-Based Trial , 2017, Journal of the National Cancer Institute.
[31] M. García-Closas,et al. iCARE: R package to build, validate and apply absolute risk models , 2016, bioRxiv.
[32] W. Willett,et al. Breast Cancer Risk From Modifiable and Nonmodifiable Risk Factors Among White Women in the United States. , 2016, JAMA oncology.
[33] S. Cummings,et al. Breast cancer risk prediction using a clinical risk model and polygenic risk score , 2016, Breast Cancer Research and Treatment.
[34] Karla Kerlikowske,et al. The contributions of breast density and common genetic variation to breast cancer risk. , 2015, Journal of the National Cancer Institute.
[35] M. García-Closas,et al. Combined associations of genetic and environmental risk factors: implications for prevention of breast cancer. , 2014, Journal of the National Cancer Institute.
[36] Anne Marie McCarthy,et al. Incremental impact of breast cancer SNP panel on risk classification in a screening population of white and African American women , 2013, Breast Cancer Research and Treatment.
[37] N. Ascunce,et al. Recalibration of the Gail model for predicting invasive breast cancer risk in Spanish women: a population-based cohort study , 2013, Breast Cancer Research and Treatment.
[38] Mitchell H Gail,et al. Projecting individualized absolute invasive breast cancer risk in Asian and Pacific Islander American women. , 2011, Journal of the National Cancer Institute.
[39] Victoria L. Cafourek,et al. Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. , 2011, Journal of the National Cancer Institute.
[40] L. Hedges,et al. Introduction to Meta‐Analysis , 2009, International Coaching Psychology Review.
[41] D Spiegelman,et al. Validation of the Gail et al. model for predicting individual breast cancer risk. , 1994, Journal of the National Cancer Institute.
[42] Mahesh S. Patel. An introduction to meta-analysis. , 1989, Health policy.
[43] D. Cox. Regression Models and Life-Tables , 1972 .